<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6889196</article-id>
    <article-id pub-id-type="publisher-id">3218</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-019-3218-2</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Methodology Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Menghan</given-names>
        </name>
        <address>
          <email>menghan.wang@uky.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Tianxin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Jinpeng</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Li</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stromberg</surname>
          <given-names>Arnold J.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Villano</surname>
          <given-names>John L.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Arnold</surname>
          <given-names>Susanne M.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Chunming</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8984-4995</contrib-id>
        <name>
          <surname>Wang</surname>
          <given-names>Chi</given-names>
        </name>
        <address>
          <email>chi.wang@uky.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8438</institution-id><institution-id institution-id-type="GRID">grid.266539.d</institution-id><institution>Department of Statistics, University of Kentucky, </institution></institution-wrap>Lexington, USA </aff>
      <aff id="Aff2"><label>2</label>Department of Molecular &amp; Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, USA </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8438</institution-id><institution-id institution-id-type="GRID">grid.266539.d</institution-id><institution>Markey Cancer Center, University of Kentucky, </institution></institution-wrap>Lexington, USA </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8438</institution-id><institution-id institution-id-type="GRID">grid.266539.d</institution-id><institution>Department of Biostatistics, University of Kentucky, </institution></institution-wrap>Lexington, USA </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8438</institution-id><institution-id institution-id-type="GRID">grid.266539.d</institution-id><institution>Department of Internal Medicine, University of Kentucky, </institution></institution-wrap>Lexington, USA </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8438</institution-id><institution-id institution-id-type="GRID">grid.266539.d</institution-id><institution>Department of Molecular &amp; Cellular Biochemistry, University of Kentucky, </institution></institution-wrap>Lexington, USA </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>2</day>
      <month>12</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>2</day>
      <month>12</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>20</volume>
    <elocation-id>620</elocation-id>
    <history>
      <date date-type="received">
        <day>1</day>
        <month>6</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>11</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2019</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Cancer arises through accumulation of somatically acquired genetic mutations. An important question is to delineate the temporal order of somatic mutations during carcinogenesis, which contributes to better understanding of cancer biology and facilitates identification of new therapeutic targets. Although a number of statistical and computational methods have been proposed to estimate the temporal order of mutations, they do not account for the differences in the functional impacts of mutations and thus are likely to be obscured by the presence of passenger mutations that do not contribute to cancer progression. In addition, many methods infer the order of mutations at the gene level, which have limited power due to the low mutation rate in most genes.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">In this paper, we develop a <underline>P</underline>robabilistic <underline>A</underline>pproach for estimating the <underline>T</underline>emporal <underline>O</underline>rder of <underline>P</underline>athway mutations by leveraging functional <underline>A</underline>nnotations of mutations (PATOPA). PATOPA infers the order of mutations at the pathway level, wherein it uses a probabilistic method to characterize the likelihood of mutational events from different pathways occurring in a certain order. The functional impact of each mutation is incorporated to weigh more on a mutation that is more integral to tumor development. A maximum likelihood method is used to estimate parameters and infer the probability of one pathway being mutated prior to another. Simulation studies and analysis of whole exome sequencing data from The Cancer Genome Atlas (TCGA) demonstrate that PATOPA is able to accurately estimate the temporal order of pathway mutations and provides new biological insights on carcinogenesis of colorectal and lung cancers.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">PATOPA provides a useful tool to estimate temporal order of mutations at the pathway level while leveraging functional annotations of mutations.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Carcinogenesis</kwd>
      <kwd>Somatic mutations</kwd>
      <kwd>Pathway analysis</kwd>
      <kwd>Functional annotations</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>Â© The Author(s) 2019</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p>Carcinogenesis is a complex process which involves somatic mutations in a number of key biological pathways and processes. Better understanding the temporal order of somatic mutation occurrences is very important to study the biological mechanism of cancer development and to inform new therapeutic targets. For some cancer types, the temporal order of mutations have been well studied. For example, colorectal cancer is frequently initiated by mutations that affect the Wnt signaling pathway, and then progress upon subsequent mutations in genes involved in MAPK, PI3K, TGF-beta, and p53 signaling pathways [<xref ref-type="bibr" rid="CR1">1</xref>]. However, for many other cancer types, temporal orders of mutations are still largely unknown.</p>
    <p>Large-scale somatic mutation profiling via whole-exome or whole-genome sequencing has provided an unprecedented opportunity for using statistical and computational methods to study carcinogenesis. A number of methods have been developed to infer temporal order of somatic mutations based on cross-sectional genomic sequencing data. One class of methods use a single oncogenetic tree or a mixture of trees to characterize temporal order of mutations [<xref ref-type="bibr" rid="CR2">2</xref>â<xref ref-type="bibr" rid="CR4">4</xref>]. A stringent constraint of these methods is that they preclude the possibility of convergence of different paths when different mutations yield the same outcome. A more flexible class of methods [<xref ref-type="bibr" rid="CR5">5</xref>â<xref ref-type="bibr" rid="CR11">11</xref>] consider progression networks, which do not assume a tree-like dependency structure among mutations. However, these methods still require full modeling of the dependency structure among mutations. As an alternative, Youn and Simon [<xref ref-type="bibr" rid="CR12">12</xref>] proposed a probabilistic method to directly estimate the order of mutations without an explicit modeling of the dependency structure.</p>
    <p>All the aforementioned methods infer tumor progression at the gene level. However, different patients have mutations in different genes and mutation rates for most genes are very low. Therefore, the power of gene level analysis is usually low. One main reason for this mutational heterogeneity is the mutual exclusivity of gene mutations in a biological pathway [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Different patients may have different driver mutations from the same pathway with a converged phenotype of perturbing the pathway. Therefore, studying temporal order of mutations at the pathway level rather than individual gene level is biologically more meaningful. Further, the mutation rate of a pathway is much higher than that of an individual gene so pathway analysis provides a stronger signal on co-occurrence of mutations in different samples, which is the primary information used in tumor progression inference. Because of these advantages, there has been a growing interest to develop methods to perform temporal order analysis at the pathway level [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>â<xref ref-type="bibr" rid="CR17">17</xref>].</p>
    <p>A major limitation of current methods is that all mutations are treated equally. A gene or pathway is considered to be functionally altered as long as a non-synonymous mutation occurs in the gene or pathway. However, many non-synonymous mutations are passenger mutations that do not contribute to cancer progression. Failing to control for such noise may lead to spurious results. The impact of passenger mutations may get worse at the pathway level because of an elevated noise level due to the increased number of mutations [<xref ref-type="bibr" rid="CR16">16</xref>]. One approach for dealing with the noise is to incorporate functional annotation of each mutation in the analysis. Quantification of the functional impact of a mutation has been well studied. Several bioinformatics tools, such as SIFT [<xref ref-type="bibr" rid="CR18">18</xref>], PolyPhen-2 [<xref ref-type="bibr" rid="CR19">19</xref>], Mutation Assessor [<xref ref-type="bibr" rid="CR20">20</xref>], and PROVBEAN [<xref ref-type="bibr" rid="CR21">21</xref>], have been developed to predict the potential effect of a mutation on the stability and function of human proteins. These prediction tools output a probabilistic score to quantify the likelihood for a mutation to be âfunctional,â i.e. having an effect on the molecular function causing diseases. Incorporating such information should enhance the accuracy of temporal order analysis of mutations.</p>
    <p>In this paper, we propose PATOPA, a probabilistic method to characterize the temporal order of mutations at the pathway level. PATOPA incorporates the functional annotation of each mutation and weigh more on mutations that are likely to be functional. To our knowledge, this is the first attempt to incorporate functional impact into mutation temporal order analysis. Simulation studies are performed to evaluate the accuracy of PATOPA on estimating the temporal order of pathway mutations and to assess the effect of functional impact scores on the estimation. PATOPA has been applied to colorectal and lung whole exome sequencing datasets from TCGA.</p>
  </sec>
  <sec id="Sec2" sec-type="results">
    <title>Results</title>
    <sec id="Sec3">
      <title>PATOPA overview</title>
      <p>An overview of PATOPA is provided in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>. We start from profiles of non-silent somatic mutations along with their associated pathway and functional annotation information for a cohort of patients at various stages of a certain type of cancer. We perform the temporal order analysis at the pathway level instead of individual gene level. A pathway is considered as being functionally altered only if at least one functional mutation has occurred. We use a probabilistic model to estimate a pivotal probability matrix <italic>P</italic> on the ordering of functional mutational events, where the (<italic>k</italic>,<italic>i</italic>) element of the matrix, <italic>p</italic><sub><italic>k</italic>,<italic>i</italic></sub>, indicates the probability of the <italic>k</italic>th functional mutation occurring in the <italic>i</italic>th pathway. Based on this pivotal probability matrix, we calculate the temporal order probability of one pathway being altered before or after another pathway. Finally, we use a partial order plot to summarize the temporal order of all the pathways.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Overview of PATOPA. Suppose we are to determine the temporal order of alterations in four pathways, A, B, C and D. The mutation data for pathways <italic>A</italic>, containing genes <italic>A</italic><sub>1</sub>, <italic>A</italic><sub>2</sub>, <italic>A</italic><sub>3</sub>, and <italic>B</italic>, containing genes <italic>B</italic><sub>1</sub>, <italic>B</italic><sub>2</sub>, <italic>B</italic><sub>3</sub>, are illustrated in the figure using colors, where a darker color indicates a mutation that is more likely to be functional and a lighter color indicates a mutation that is less likely to be functional based on functional annotation. PATOPA integrates the mutation data, pathway information, and functional annotations to estimate a pivotal probability matrix <italic>P</italic>, where the (<italic>k</italic>,<italic>i</italic>) element of the matrix indicates the probability of the <italic>k</italic>th functional mutation occurring in the <italic>i</italic>th pathway. Based on <italic>P</italic>, we infer the temporal order of the four pathways, where <italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>) is the probability of A being altered before <italic>B</italic> and <italic>P</italic>(<italic>B</italic>&lt;<italic>A</italic>) is the probability of <italic>B</italic> being altered before <italic>A</italic>. Based on those probabilities, a partial order plot is constructed to show the carcinogenesis process, where the thickness of an edge from <italic>A</italic> to <italic>B</italic> is determined by <italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>)</p></caption><graphic xlink:href="12859_2019_3218_Fig1_HTML" id="MO1"/></fig></p>
      <p>The idea of PATOPA can be illustrated by an example of determining the temporal order of pathways A and B in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>. Notice that all patients who have mutations in pathway B (patients 2, 3 and 5) also have mutations in pathway A. On the other side, patients 1 and 4 only have mutations in pathway A, but not in pathway B. As we assume driver mutations occur in a sequence, such data would suggest that pathway A is likely to be alterred before pathway B during carcinogenesis. This idea was originated by Youn and Simon [<xref ref-type="bibr" rid="CR12">12</xref>]. In this paper, we make two major extensions. The first extension is to consider the temporal order at the pathway level instead of gene level, which substantially increases the power. As shown in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>, the mutation frequency of an individual gene is low. For example, genes <italic>A</italic><sub>2</sub> and <italic>B</italic><sub>3</sub> only have one mutation each, and the mutations are in different patients. Therefore, there is no sufficient information to confidently determine the temporal order of mutations in these two genes. In contrast, when pooling genes from the same pathway together, the mutation frequency increases substantially for both pathways so that the temporal order estimation becomes more feasible. The second extension is to incorporate functional annotation information to improve the inference. As shown in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>, patient 5 has mutations in both pathways A and B. If we ignore functional annotation information, data from this patient is not informative to indicate the order of the two pathways. However, based on functional annotation, the mutation in pathway A is likely a functional mutation while the one in pathway B is likely a non-functional mutation. With this added piece of information, data from this patient is useful to support that pathway A is alterred before pathway B.</p>
    </sec>
    <sec id="Sec4">
      <title>Optimization for computational efficiency</title>
      <p>PATOPA involves estimation of the parameter matrix <italic>P</italic>, where the size of the matrix is determined by the number of pathways and the number of functional mutation events. Without control of these two numbers, <italic>P</italic> can contain a large number of parameters, which makes the estimation computationally intensive. We used the following two approaches to reduce number of parameters in <italic>P</italic>. Firstly, we performed our analysis for each pair of pathways seperately to estimate <italic>P</italic> and temporal order probabilities. This approach substantially reduces the number of columns in <italic>P</italic>, and therefore is computationally much more efficient. To examine the performance of this approach, we used TCGA rectal cancer data and analyzed 9 key cancer pathways from the Kyoto Encyclopedia of Genes and Genome (KEGG) database [<xref ref-type="bibr" rid="CR22">22</xref>]. A more detailed description of the dataset and pathway information is provided in the â<xref rid="Sec8" ref-type="sec">Real data analysis</xref>â section. The left panel of Fig.Â <xref rid="Fig2" ref-type="fig">2</xref> compares the estimated temporal order probabilities from analyzing each pair of pathways at a time versus all pathways together. The differences were small with most of the values less than 0.1. Therefore, we used this pairwise analysis approach in the rest of the paper.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Validity of approaches to improve computational efficacy. Left panel: difference in estimated temporal order probabilities from analyzing each pair of pathways at a time versus all pathways together; right panel: difference in estimated temporal order probabilities between adjacent <italic>K</italic> values, where each boxplot indicates the distribution of difference in estimated probabilities between <italic>K</italic> and <italic>K</italic>â1 across all the 36 pairs of key pathways based on TCGA rectal cancer data</p></caption><graphic xlink:href="12859_2019_3218_Fig2_HTML" id="MO2"/></fig></p>
      <p>Secondly, we set <italic>p</italic><sub><italic>k</italic>,<italic>i</italic></sub>=<italic>p</italic><sub><italic>K</italic>,<italic>i</italic></sub> for <italic>k</italic>&gt;<italic>K</italic> and estimated an averaged distribution for mutations occurring after the <italic>K</italic>-th step. To choose an appropriate <italic>K</italic> value, we again used the TCGA rectal cancer data and compared estimated temporal order probabilities between adjacent <italic>K</italic> values for 36 pairs of the 9 key pathways. FigureÂ <xref rid="Fig2" ref-type="fig">2</xref> right panel shows that the estimated temporal order probabilities became very stable for <italic>K</italic>â¥4. In addition, for each pair of pathways, we calculated the probability distribution of number of functional mutations they would contain (see Additional fileÂ <xref rid="MOESM1" ref-type="media">1</xref>: Figure S10). The probability of having more than 4 functional mutations for most pairs of pathways was very small. Therefore, we set <italic>K</italic>=4 in our subsequent analyses.</p>
    </sec>
    <sec id="Sec5">
      <title>Simulation studies</title>
      <sec id="Sec6">
        <title>Evaluating the estimation accuracy of the temporal order of pathway mutations</title>
        <p>Simulation studies were conducted to evaluate the performance of PATOPA in determining the temporal order of two pathways, A and B. Our goal was to use simulated datasets that we knew the true pathway order probabilities to investigate whether PATOPA was able to uncover those probabilities when analyzing the datasets. To mimic real world situation, we set the true pathway order probabilities based on TCGA rectal cancer mutation data from the p53 signaling (our pathway A, 8 genes) and cell cycle (our pathway B, 89 genes) pathways. Specifically, we applied PATOPA to TCGA rectal cancer data to estimate <italic>p</italic><sub><italic>k</italic>,<italic>A</italic></sub> and <italic>p</italic><sub><italic>k</italic>,<italic>B</italic></sub>, the probability that the <italic>k</italic>th functional mutation was from pathways A and B, respectively. We also calculated the probabilities of pathway <italic>A</italic> being altered before (<italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>)), simultaneously with (<italic>P</italic>(<italic>A</italic>=<italic>B</italic>)), and after (<italic>P</italic>(<italic>A</italic>&gt;<italic>B</italic>)) pathway <italic>B</italic> being altered. These probability values were set as true values to simulate data based on the following procedure. Firstly, the number of functional and non-functional mutations in a patient were generated based on the empirical distributions in TCGA rectal cancer data, respectively. Secondly, functional mutations were assigned to pathways in a temporal order, where the <italic>k</italic>th functional mutation was assigned to pathway A with probability <italic>p</italic><sub><italic>k</italic>,<italic>A</italic></sub>, or to pathway B with probability <italic>p</italic><sub><italic>k</italic>,<italic>B</italic></sub>. Thirdly, non-functional mutations were randomly assigned to the two pathways with probabilities <italic>q</italic><sub><italic>i</italic></sub>, the probability that a randomly sampled non-functional mutation is from pathway <italic>i</italic> for <italic>i</italic>=<italic>A</italic> or <italic>B</italic>. Fourthly, the functional impact score of each gene mutation was assigned as the conditional probability of observing this specific mutation given that there was a functional/non-functional mutation in the pathway that this gene belonged to.</p>
        <p>We simulated data of sample size 50, 100, 200 or 400 with 100 replicates at each sample size. We applied PATOPA to simulated datasets to estimate <italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>), <italic>P</italic>(<italic>A</italic>=<italic>B</italic>) and <italic>P</italic>(<italic>A</italic>&gt;<italic>B</italic>). To quantify the difference between true probability values we set when simulating the data and estimated probability values from PATOPA, we define the bias as the mean absolute difference between true and estimated probability values across 100 simulations. As shown in TableÂ <xref rid="Tab1" ref-type="table">1</xref>, the bias was small, indicating that PATOPA was able to accurately estimate those probabilities. In addition, the bias decreased as the sample size increased, indicating that PATOPA had increased precision in estimating those probabilities when more data were available.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Estimation accuracy of PATOPA. Numbers presented are the bias, i.e. the difference between the estimated and true values averaged across 100 simulation replicates</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Sample size</th><th align="left"><italic>P</italic>(<italic>A</italic>&gt;<italic>B</italic>)</th><th align="left"><italic>P</italic>(<italic>A</italic>=<italic>B</italic>)</th><th align="left"><italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>)</th></tr></thead><tbody><tr><td align="left">50</td><td align="left">0.074</td><td align="left">0.069</td><td align="left">0.041</td></tr><tr><td align="left">100</td><td align="left">0.048</td><td align="left">0.045</td><td align="left">0.028</td></tr><tr><td align="left">200</td><td align="left">0.038</td><td align="left">0.034</td><td align="left">0.021</td></tr><tr><td align="left">400</td><td align="left">0.021</td><td align="left">0.020</td><td align="left">0.013</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec7">
        <title>Evaluating the effect of functional impact scores</title>
        <p>We performed another set of simulations to assess the effect of functional impact score on the estimation of temporal order probabilities. Under the same simulation setting described in the previous subsection, we increased or decreased the PolyPhen-2 scores of all mutations in the p53 signaling pathway (pathway A). The resulting probabilities are presented in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>. It shows the trend that when PolyPhen-2 scores of mutations in pathway A were decreased, <italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>) decreased and <italic>P</italic>(<italic>A</italic>&gt;<italic>B</italic>) increased. Specifically, when functional impact scores of all pathway A mutations were decreased by 0.5, <italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>) decreased to 0.25. When scores were increased by 0.5, <italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>) increased to 0.7. The results demonstrate the substantial impact of functional impact score that can lead to distinct inference on the temporal order of pathways.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Effect of functional impact scores on the inference of temporal order of pathway mutations. PolyPhen-2 scores of all mutations in pathway A were changed by a certain amount and the corresponding estimated temporal order probabilities were presented</p></caption><graphic xlink:href="12859_2019_3218_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Real data analysis</title>
      <p>To further evaluate the performance of PATOPA, we applied it to TCGA whole exome sequencing data for colorectal and lung cancer data. We considered 9 key cancer pathways in our analysis. In addition to the canonical molecular signaling pathways of wingless-related integration site (WNT), mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K), transforming growth factor beta (TGF-beta), p53 and vascular endothelial growth factor (VEGF), we also included pathways involving the processes of apoptosis, adherens junction and cell cycle. The apoptosis pathway is an indicator of turnover of both normal and tumor cells; the adherens junction pathway is an important factor for tumor invasion; and the cell cycle pathway suggests the process of cell growth in the tumor. Genes in each of the 9 pathways, which are listed in Additional fileÂ <xref rid="MOESM1" ref-type="media">1</xref>: Table S1, were determined based on the KEGG database [<xref ref-type="bibr" rid="CR22">22</xref>] with manual curation.</p>
      <sec id="Sec9">
        <title>Analysis of TCGA colorectal cancer data</title>
        <p>The TCGA project provided the whole exome sequencing data of 461 colon and 172 rectal tumor samples. Since we aimed to better understand the similarity and difference of carcinogenesis between colon and rectal cancers, we analyzed these two datasets separately. For each cancer type, we deleted the top 16% hyper-mutated samples because the carcinogenesis process of these tumors involve different sequences of genetic events [<xref ref-type="bibr" rid="CR23">23</xref>]. We applied PATOPA to estimate temporal order probabilities of each pair of pathways and the results are summarized by partial order plots (Figs.Â <xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>). The comparison between the orders PATOPA found from seperate analysis of rectal cancer and colon cancer mutation data and those reported in the literature for colorectal combined tumor [<xref ref-type="bibr" rid="CR1">1</xref>] is presented in Figure S11 in Additional fileÂ <xref rid="MOESM1" ref-type="media">1</xref>. Most of the inferred temporal orders of pathway mutations were consistent with cancer research literature. Specifically, the estimated temporal orders of WNT - MAPK - PI3K - p53 signaling pathways for rectal cancer and WNT - MAPK - PI3K - TGF-beta signaling pathways for colon cancer were the same as the known sequences of biological events in colorectal cancer [<xref ref-type="bibr" rid="CR1">1</xref>]. Interestingly, the TGF-beta pathway were placed before the MAPK pathway from our analysis of rectal cancer alone (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>), and the p53 signaling pathway was placed before the PI3K and TGF-beta signaling pathways from our analysis of colon cancer alone (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>), which are cancer type-specific and distinct from the biological evidence for âcolorectalâ combined tumor [<xref ref-type="bibr" rid="CR1">1</xref>]. This might be due to the lack of biological evidence from the isolated rectal and colon cancer samples separately and the traditional method for tissue collection and analysis from colorectal cancer patients. Also, traditional biological analysis only considered very limited number of gene mutations in each pathway, while PATOPA analysis considered all of the available mutations in each defined pathway.
<fig id="Fig4"><label>Fig. 4</label><caption><p>Estimated order of pathway alterations based on TCGA rectal cancer dataset. Estimated temporal order probabilities from PATOPA are summarized using a partial order plot [<xref ref-type="bibr" rid="CR24">24</xref>]. Each node corresponds to a pathway we analyzed. The nodes/pathways are ordered based on the temporal order probabilities estimated from PATOPA. The thickness of a directed edge is proportional to the probability that the head node is mutated after the tail node. Pathways with similar temporal order probabilities are clustered together, where the clustering results are indicated by different colors of node borders. For better visualization, edges with probability less than 0.4 are removed from this figure</p></caption><graphic xlink:href="12859_2019_3218_Fig4_HTML" id="MO4"/></fig>
<fig id="Fig5"><label>Fig. 5</label><caption><p>Estimated order of pathway alterations based on TCGA colon cancer dataset. Estimated temporal order probabilities from PATOPA are summarized using a partial order plot [<xref ref-type="bibr" rid="CR24">24</xref>]. Each node corresponds to a pathway we analyzed. The nodes/pathways are ordered based on the temporal order probabilities estimated from PATOPA. The thickness of a directed edge is proportional to the probability that the head node is mutated after the tail node. Pathways with similar temporal order probabilities are clustered together, where the clustering results are indicated by different colors of node borders. For better visualization, edges with probability less than 0.4 are removed from this figure</p></caption><graphic xlink:href="12859_2019_3218_Fig5_HTML" id="MO5"/></fig></p>
        <p>To better illustrate how the incorporation of functional impact scores benefited our analysis, we studied the distribution of PolyPhen-2 scores for each pathway using TCGA rectal and colon cancer datasets, see Figure S12 in Additional fileÂ <xref rid="MOESM1" ref-type="media">1</xref>. The Wnt signaling pathway had more mutations with high PolyPhen-2 scores than the MAPK and p53 signaling pathways, which supports our model inference that the Wnt signaling pathway was altered prior to the MAPK and p53 signaling pathways. Our model is based on the idea that only mutations affecting protein functions should be used to infer mutational order of pathways. Since the PolyPhen-2 score quantifies the probability of each mutation being functional, pathways having more mutations with high PolyPhen-2 scores tend to be ordered earlier than pathways having fewer such mutations.</p>
      </sec>
      <sec id="Sec10">
        <title>Analysis of TCGA lung cancer data</title>
        <p>Non-small cell lung cancer is another significant cancer type to our interest, which is primarily composed of two clinically and pathologically different subtype groups, i.e. lung adenocarcinoma and lung squamous cell carcinoma. We applied PATOPA to the whole-exome sequencing data of 585 lung adenocarcinoma samples and 504 lung squamous cell carcinoma samples in TCGA. The resulting partial order plots are shown in Fig.Â <xref rid="Fig6" ref-type="fig">6</xref> and Fig.Â <xref rid="Fig7" ref-type="fig">7</xref>. The mutations in the MAPK signaling pathway ranked on the top of lung adenocarcinoma. This is not surprising as KRAS is the most frequently mutated gene in the lung adenocarcinoma but less frequent in the lung squamous cell carcinoma [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. In both lung adenocarcinoma and squamous cell carcinoma, the mutations of the Wnt signaling ranked just below the MAPK signaling. It has been reported that activation of both Wnt signaling and KRAS dramatically enhanced lung carcinogenesis [<xref ref-type="bibr" rid="CR27">27</xref>]. However, from biological evidences, the most prevalent mutations found in lung cancer are those of p53 signaling pathway. Interestingly, we notice that mutation of the p53 pathway appeared to be in distinct positions of orders in lung adenocarcinoma and squamous cell carcinoma. While p53 pathway mutation was downstream of most of the other pathway mutations in lung adenocarcinoma, it was at the upstream of all signaling pathway mutations in lung squamous cell carcinoma (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref> and Fig.Â <xref rid="Fig7" ref-type="fig">7</xref>). Previous findings suggest that p53 pathway mutations are involved in 80% of lung squamous cell carcinoma, while the mutations are involved in 50% of lung adenocarcinoma [<xref ref-type="bibr" rid="CR28">28</xref>]. Our model explains the possibility that in lung squamous cell carcinoma, p53 pathway plays a more fundamental role in initiating the tumor cell growth than in lung adenocarcinoma.
<fig id="Fig6"><label>Fig. 6</label><caption><p>Estimated order of pathway alterations based on TCGA lung adenocarcinoma dataset. Estimated temporal order probabilities from PATOPA are summarized using a partial order plot [<xref ref-type="bibr" rid="CR24">24</xref>]. Each node corresponds to a pathway we analyzed. The nodes/pathways are ordered based on the temporal order probabilities estimated from PATOPA. The thickness of a directed edge is proportional to the probability that the head node is mutated after the tail node. Pathways with similar temporal order probabilities are clustered together, where the clustering results are indicated by different colors of node borders. For better visualization, edges with probability less than 0.4 are removed from this figure</p></caption><graphic xlink:href="12859_2019_3218_Fig6_HTML" id="MO6"/></fig>
<fig id="Fig7"><label>Fig. 7</label><caption><p>Estimated order of pathway alterations based on TCGA lung squamous cell carcinoma dataset. Estimated temporal order probabilities from PATOPA are summarized using a partial order plot [<xref ref-type="bibr" rid="CR24">24</xref>]. Each node corresponds to a pathway we analyzed. The nodes/pathways are ordered based on the temporal order probabilities estimated from PATOPA. The thickness of a directed edge is proportional to the probability that the head node is mutated after the tail node. Pathways with similar temporal order probabilities are clustered together, where the clustering results are indicated by different colors of node borders. For better visualization, edges with probability less than 0.4 are removed from this figure</p></caption><graphic xlink:href="12859_2019_3218_Fig7_HTML" id="MO7"/></fig></p>
      </sec>
      <sec id="Sec11">
        <title>Comparison to other method</title>
        <p>We compared PATOPA with an existing method, H-CBN [<xref ref-type="bibr" rid="CR15">15</xref>]. We focused our comparison on colorectal cancer, for which the temporal order of pathway alterations is better understood in cancer research literature. We applied H-CBN to TCGA rectal and colon data. The obtained pathway order estimates are provided in Additional fileÂ <xref rid="MOESM1" ref-type="media">1</xref>: Figure S13. For rectal cancer, H-CBN was able to infer that Wnt pathway was alterred before MAPK pathway, and MAPK pathway was alterred before PI3K-Akt pathway. However, it was unable to determine the orders of Wnt/MAPK/PI3K and p53 and TGF-beta pathways. Therefore, temporal orders inferred by PATOPA were closer to the cancer research literature than those inferred by H-CBN. For colon cancer, H-CBN was able to infer the orders of MAPK and PI3K pathways, and MAPK and p53 pathways. However, H-CBN was unable to determine the order of MAPK/PI3K/p53 and Wnt and TGF-beta pathways. Therefore, the results from H-CBN were less informative that those from PATOPA.</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec12" sec-type="discussion">
    <title>Discussion</title>
    <p>Inferring temporal order of driver mutations during carcinogenesis is an important task in the analysis of whole genome/exome sequencing data. Considering mutations at the pathway level rather than individual gene level is biologically meaningful and can substantially increase the power of the analysis. We focused on 9 KEGG cancer-related pathways in our data analysis. But our method is generally applicable to study alterations of other biological pathways or gene sets including de novo driver gene sets identified from computational algorithms [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p>
    <p>In our analysis, we used PolyPhen-2 score [<xref ref-type="bibr" rid="CR19">19</xref>] to characterize the probability of each mutation being functional. Other scores, such as SIFT [<xref ref-type="bibr" rid="CR18">18</xref>], Mutation Assessor [<xref ref-type="bibr" rid="CR20">20</xref>] and PROVBEAN [<xref ref-type="bibr" rid="CR21">21</xref>], can also be used alternatively. One limitation of our analysis is that we only considered single nucleotide variants and did not include copy number variants. Incorporating copy number variants into the analysis is our future work.</p>
    <p>Our data analysis did not account for cancer subtypes [<xref ref-type="bibr" rid="CR30">30</xref>â<xref ref-type="bibr" rid="CR33">33</xref>]. It would be interesting to perform the analysis within each cancer subtype separately and compare the temporal order of pathway alterations between different subtypes. Such analysis may identify subtype-specific pathway alteration orders and better understand the development process of a certain cancer subtype, although the sample size may be a limiting factor of the power of the analysis.</p>
    <p>PATOPA infers temporal order of pathway mutations based on mutation frequencies across a cohort of patients. It does not account for the intra-tumor heterogeneity [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], which may limit the methodâs ability to discern temporal order of pathway mutations in some cases. Recent advances in bioinformatic tools enables us to reconstruct the evolutionary history and population frequency of the subclonal lineages of tumor cells based on single- or multi-region sequencing of samples from an individual patient [<xref ref-type="bibr" rid="CR36">36</xref>â<xref ref-type="bibr" rid="CR38">38</xref>]. In addition, emerging single-cell sequencing technologies [<xref ref-type="bibr" rid="CR39">39</xref>â<xref ref-type="bibr" rid="CR41">41</xref>] have the promise of revealing tumor heterogeneity at a much higher resolution. Tumor evolutionary lineage can be reconstructed [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>] based on single-cell sequencing data. Incorporating intra-tumor heterogeneity and tumor evolution information may substantially improve the estimation of pathway mutation orders, which is an important direction of future research.</p>
  </sec>
  <sec id="Sec13" sec-type="conclusion">
    <title>Conclusions</title>
    <p>In this article, we have proposed PATOPA, a new probabilistic method for inferring the temporal order of pathway mutations during carcinogenesis based on whole genome/exome sequencing data and functional impact scores of mutations. The method can be a useful tool to help researchers better understand the process of tumor development. The result obtained by applying our method to TCGA rectal cancer whole-exome sequencing data is mostly consistent with the multi-step process of colorectal carcinogenesis established by previous research, which provides a degree of validation of the ability of our method to recover mutation order of pathways from a cross-sectional dataset.</p>
  </sec>
  <sec id="Sec14">
    <title>Methods</title>
    <sec id="Sec15">
      <title>A probabilistic approach</title>
      <p>Our goal is to determine the order of <italic>N</italic> pathways. We first consider the case that all the pathways do not have any gene in overlap. An extension of our method to the case of overlapping pathways is provided at the end of this subsection. Let <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$Y^{j}_{i}$\end{document}</tex-math><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq1.gif"/></alternatives></inline-formula> be the observed number of non-synonymous mutations in pathway <italic>i</italic> of patient j for <italic>i</italic>=1,â¦,<italic>N</italic>, <italic>j</italic>=1,â¦,<italic>M</italic>, and <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$m_{j} = \sum _{i=1}^{N} Y_{i}^{j}$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:munderover><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq2.gif"/></alternatives></inline-formula> be the total number of non-silent mutations in patient <italic>j</italic>. Let <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$S_{k}^{j}$\end{document}</tex-math><mml:math id="M6"><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq3.gif"/></alternatives></inline-formula> indicate whether the <italic>k</italic>th mutation is functional (<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$S_{k}^{j}$\end{document}</tex-math><mml:math id="M8"><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq4.gif"/></alternatives></inline-formula>=1) or not (<inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$S_{k}^{j}$\end{document}</tex-math><mml:math id="M10"><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq5.gif"/></alternatives></inline-formula>=0) for <italic>k</italic>=1,â¦,<italic>m</italic><sub><italic>j</italic></sub>, and <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$n_{j}=\sum _{k=1}^{m_{j}} S_{k}^{j}$\end{document}</tex-math><mml:math id="M12"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:munderover><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq6.gif"/></alternatives></inline-formula> be the total number of functional mutations in patient <italic>j</italic>. Based on the law of total probability, the probability of observing the set of <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$Y^{j}_{i}$\end{document}</tex-math><mml:math id="M14"><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq7.gif"/></alternatives></inline-formula> can be expressed as
<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document} $$ \begin{aligned} &amp;P(Y^{j}_{1}, \ldots, Y^{j}_{N})\\ =&amp; \Sigma \left. P(Y^{j}_{1}, \ldots, Y^{j}_{N}|S_{1}^{j},...,S_{m_{j}}^{j},m_{j}) P(S_{1}^{j},...,S_{m_{j}}^{j} | m_{j})P(m_{j}),\right. \end{aligned}  $$ \end{document}</tex-math><mml:math id="M16"><mml:mtable><mml:mtr><mml:mtd><mml:mtable><mml:mtr><mml:mtd><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>=</mml:mo></mml:mtd><mml:mtd><mml:mi>Î£</mml:mi><mml:mfenced close="" open="" separators=""><mml:mrow><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>|</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi>...</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi>...</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="12859_2019_3218_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
      <p>where the summation is over all possible sequences of <inline-formula id="IEq8"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$S_{1}^{j},...S_{m_{j}}^{j}$\end{document}</tex-math><mml:math id="M18"><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi>...</mml:mi><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq8.gif"/></alternatives></inline-formula>. We next describe how to calculate each of the three terms in the summation. For the first term, let <inline-formula id="IEq9"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$D^{j}_{k}$\end{document}</tex-math><mml:math id="M20"><mml:msubsup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq9.gif"/></alternatives></inline-formula> denote the unknown identity of the pathway mutated as the <italic>k</italic>th functional event, and <inline-formula id="IEq10"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$N^{j}_{v}$\end{document}</tex-math><mml:math id="M22"><mml:msubsup><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq10.gif"/></alternatives></inline-formula> denote the unknown identity of the pathway mutated as the <italic>v</italic>th nondamaging event in patient <italic>j</italic>. We have
<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document} $$ {\begin{aligned}  &amp;  P(Y^{j}_{1}, \ldots, Y^{j}_{N}|S_{1}^{j},...S_{m_{j}}^{j},m_{j}) \\ = \Sigma &amp;P(D^{j}_{1}=i_{1}, \ldots, D^{j}_{n_{j}}=i_{n_{j}},N^{j}_{1}=i_{n_{j}+1}, \ldots,N^{j}_{m_{j}-n_{j}}=i_{m_{j}} |S_{1}^{j}, \\ &amp;\ldots, S_{m_{j}}^{j}, m_{j}) \\ =\Sigma &amp;P(D^{j}_{1}=i_{1}, \ldots, D^{j}_{n_{j}}=i_{n_{j}}|S_{1}^{j}, \ldots, S_{m_{j}}^{j}, m_{j}) \\ &amp;\times P(N^{j}_{1}=i_{n_{j}+1}, \ldots,N^{j}_{m_{j}-n_{j}}=i_{m_{j}} |S_{1}^{j}, \ldots, S_{m_{j}}^{j}, m_{j}), \end{aligned}}  $$ \end{document}</tex-math><mml:math id="M24"><mml:mspace width="-14.0pt"/><mml:mtable><mml:mtr><mml:mtd><mml:mspace width="-5.69046pt"/><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>|</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi>...</mml:mi><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>=</mml:mo><mml:mi>Î£</mml:mi></mml:mtd><mml:mtd><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>|</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>=</mml:mo><mml:mi>Î£</mml:mi></mml:mtd><mml:mtd><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>|</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>Ã</mml:mo><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>|</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="12859_2019_3218_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula></p>
      <p>where the summation is over all possible orders of pathway identities of functional and non-functional mutations, <inline-formula id="IEq11"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\phantom {\dot {i}\!}(i_{1}, \ldots, i_{m_{j}})$\end{document}</tex-math><mml:math id="M26"><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq11.gif"/></alternatives></inline-formula>, that are consistent with the observed set of mutations <inline-formula id="IEq12"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$(Y^{j}_{1}, \ldots, Y^{j}_{N})$\end{document}</tex-math><mml:math id="M28"><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq12.gif"/></alternatives></inline-formula>, and the last equation is obtained by assuming the occurrences of functional mutations and non-functional mutations are independent. For functional mutations, let <inline-formula id="IEq13"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$p_{k,i_{k}}$\end{document}</tex-math><mml:math id="M30"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq13.gif"/></alternatives></inline-formula> be the probability that the <italic>k</italic>th functional mutation occurs in the <italic>i</italic><sub><italic>k</italic></sub>th pathway and assume that <inline-formula id="IEq14"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$p_{k,i_{k}}$\end{document}</tex-math><mml:math id="M32"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq14.gif"/></alternatives></inline-formula> is independent of <inline-formula id="IEq15"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$p_{l,i_{l}}$\end{document}</tex-math><mml:math id="M34"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq15.gif"/></alternatives></inline-formula> for <italic>l</italic>â <italic>k</italic>. The <inline-formula id="IEq16"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$p_{k,i_{k}}$\end{document}</tex-math><mml:math id="M36"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq16.gif"/></alternatives></inline-formula>âs are our parameters of interest. For non-functional mutations, as their orderings are most likely random, we assume equal probablity for each order of non-functional mutations in a given patient. Let <italic>q</italic><sub><italic>i</italic></sub> be the probability that a randomly sampled non-functional mutation is from pathway <italic>i</italic>, equation (<xref rid="Equ2" ref-type="">2</xref>) can be re-written as
<disp-formula id="Equa"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document} $$\Sigma \left(\prod \limits^{n_{j}}_{k=1} p_{k, i_{k}} \right) \left(\prod\limits_{l=n_{j}+1}^{m_{j}} q_{i_{l}} \right). $$ \end{document}</tex-math><mml:math id="M38"><mml:mrow><mml:mi>Î£</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo mathsize="big">â</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo mathsize="big">â</mml:mo></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mi>.</mml:mi></mml:mrow></mml:math><graphic xlink:href="12859_2019_3218_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
      <p>In practice, we estimate <italic>q</italic><sub><italic>i</italic></sub> by an average across samples, i.e. <inline-formula id="IEq17"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$ (\sum _{j} E_{i}^{j})/(\sum _{j} \sum _{z} E_{z}^{j}) $\end{document}</tex-math><mml:math id="M40"><mml:mo>(</mml:mo><mml:munder><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:munder><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:munder><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:munder><mml:munder><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>z</mml:mi></mml:mrow></mml:munder><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq17.gif"/></alternatives></inline-formula>, where <inline-formula id="IEq18"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$E_{z}^{j} = \sum _{k: \textrm {the }k\textrm {th mutation is from pathway }z} (1-r_{k})$\end{document}</tex-math><mml:math id="M42"><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>:</mml:mo><mml:mtext>the</mml:mtext><mml:mi>k</mml:mi><mml:mtext>th mutation is from pathway</mml:mtext><mml:mi>z</mml:mi></mml:mrow></mml:munder><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>â</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq18.gif"/></alternatives></inline-formula> is the expected number of non-functional mutations in pathway <italic>z</italic> for patient <italic>j</italic> and <inline-formula id="IEq19"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$r_{k}=P(S_{k}^{j}=1)$\end{document}</tex-math><mml:math id="M44"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq19.gif"/></alternatives></inline-formula> is the functional impact score of the <italic>k</italic>th mutation that can be obtained from software such as PolyPhen-2 [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
      <p>For the second term in equation (1), we assume <inline-formula id="IEq20"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$S_{k}^{j}$\end{document}</tex-math><mml:math id="M46"><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq20.gif"/></alternatives></inline-formula> is independent of <inline-formula id="IEq21"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$S_{l}^{j}$\end{document}</tex-math><mml:math id="M48"><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq21.gif"/></alternatives></inline-formula> for <italic>l</italic>â <italic>k</italic>. We have <inline-formula id="IEq22"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$P(S_{1}^{j},...,S_{m_{j}}^{j} | m_{j}) = \prod \limits ^{m_{j}}_{k=1} r_{k}^{S_{k}^{j}}(1-r_{k})^{1-S_{k}^{j}}$\end{document}</tex-math><mml:math id="M50"><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi>...</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msubsup><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>â</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>â</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq22.gif"/></alternatives></inline-formula>. For the third term in equation (1), since the marginal probability <italic>P</italic>(<italic>m</italic><sub><italic>j</italic></sub>) is independent of <inline-formula id="IEq23"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$p_{k,i_{k}}$\end{document}</tex-math><mml:math id="M52"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq23.gif"/></alternatives></inline-formula>, it can be ignored in the likelihood function. Therefore, the likelihood function can be written as
<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document} $$ {\begin{aligned}  \prod \limits_{j} \Sigma \left\{\Sigma \left(\prod \limits^{n_{j}}_{k=1} p_{k,i_{k}} \right) \left(\prod\limits_{l=n_{j}+1}^{m_{j}} q_{i_{l}} \right) \right\} \left\{\prod \limits^{m_{j}}_{k=1} r_{k}^{S_{k}^{j}}(1-r_{k})^{1-S_{k}^{j}}\right\}. \end{aligned}}  $$ \end{document}</tex-math><mml:math id="M54"><mml:mspace width="-10.0pt"/><mml:mtable><mml:mtr><mml:mtd><mml:munder><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:munder><mml:mi>Î£</mml:mi><mml:mfenced close="}" open="{" separators=""><mml:mrow><mml:mi>Î£</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mfenced close="}" open="{" separators=""><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo>â</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msubsup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msubsup><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>â</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>â</mml:mo><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msup></mml:mrow></mml:mfenced><mml:mi>.</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="12859_2019_3218_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula></p>
      <p>An estimate of <inline-formula id="IEq24"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$p_{k,i_{k}}$\end{document}</tex-math><mml:math id="M56"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq24.gif"/></alternatives></inline-formula> is obtained by maximizing the likelihood, see the â<xref rid="Sec17" ref-type="sec">Parameter estimation</xref>â section. Finally, the probability of pathway <italic>A</italic> being alterred prior to pathway <italic>B</italic>, denoted by <italic>P</italic>(<italic>A</italic>&lt;<italic>B</italic>), is
<disp-formula id="Equb"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document} $${} P(A\! &lt; B) = \Sigma_{\{(i_{1}, \ldots, i_{n}) \in G_{A&lt;B}\}} \left(\prod \limits^{n}_{k=1} p_{k,i_{k}}\right), n = {\underset{j \in \{1,\ldots,m\}}{\max}} \{m_{j}\} $$ \end{document}</tex-math><mml:math id="M58"><mml:mrow><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mspace width="0.3em"/><mml:mo>&lt;</mml:mo><mml:mi>B</mml:mi><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>Î£</mml:mi></mml:mrow><mml:mrow><mml:mo>{</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>â</mml:mo><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mo>}</mml:mo></mml:mrow></mml:msub><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo mathsize="big">â</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo>max</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>â</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>â¦</mml:mo><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>}</mml:mo></mml:mrow></mml:munder><mml:mo>{</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>}</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2019_3218_Article_Equb.gif" position="anchor"/></alternatives></disp-formula> where <italic>G</italic><sub><italic>A</italic>&lt;<italic>B</italic></sub> is the subset of pathway mutation sequences satisfying that the first functional mutation in <italic>A</italic> occurs before the first functional mutation in <italic>B</italic> occurs.</p>
      <p>The aforementioned method requires that the pathways have no overlap. However, many pathways in biological databases, such as KEGG [<xref ref-type="bibr" rid="CR22">22</xref>], have overlapped genes. In such situation, we regroup the genes into mutually exclusive gene sets to run the analysis. Consider an example of two pathways, <italic>A</italic> and <italic>B</italic>, with an overlapped subset <italic>A</italic>â©<italic>B</italic>. We regroup the genes into three mutually exclusive sets: <italic>A</italic><sup>â²</sup>=<italic>A</italic>â©<italic>B</italic><sup><italic>c</italic></sup>, <italic>A</italic><italic>B</italic>=<italic>A</italic>â©<italic>B</italic>, and <italic>B</italic><sup>â²</sup>=<italic>A</italic><sup><italic>c</italic></sup>â©<italic>B</italic>, and perform the analysis on those three sets. Functional mutations in <italic>A</italic><sup>â²</sup> and <italic>B</italic><sup>â²</sup> are able to delineate the temporal order of <italic>A</italic> and <italic>B</italic>. Functional mutations in <italic>AB</italic> are considered as altering both <italic>A</italic> and <italic>B</italic> simultaneously and are used to estimate such probability, i.e. <italic>P</italic>(<italic>A</italic>=<italic>B</italic>).</p>
    </sec>
    <sec id="Sec16">
      <title>Visualization</title>
      <p>We visualize the result of our analysis of each cancer type with a partial order plot [<xref ref-type="bibr" rid="CR24">24</xref>]. Each nodes in the plot corresponds to a pathway. Nodes are ordered based on estimated temporal order probabilities using the layered graph drawing method in Graphviz (version 1.3.1) [<xref ref-type="bibr" rid="CR44">44</xref>], where pathways likely to be mutated at early stage are placed on the top while pathways likely to be mutated at late stage are placed at the bottom. The thickness of a directed edge is proportional to the probability that the head node (pathway) is mutated before the tail node (pathway). For better visualization, edges with probabilities less than a threshold value are removed from the plot. In addition, we cluster pathways using the correlation clustering algorithm [<xref ref-type="bibr" rid="CR45">45</xref>], which aims to find a clustering that simultaneously maximizes the similarities (the probability that the order of two pathways cannot be determined) between clusters and minimizes the dissimilarities (the probabilities that the order of the two pathways can be determined) between clusters. The clustering results are presented by colors of the node borders.</p>
    </sec>
    <sec id="Sec17">
      <title>Parameter estimation</title>
      <p>The estimator of <italic>p</italic><sub><italic>k</italic>,<italic>i</italic></sub> is obtained by maximizing the likelihood function (<xref rid="Equ3" ref-type="">3</xref>). Since the <italic>p</italic><sub><italic>k</italic>,<italic>i</italic></sub>âs need to satisfy the constraints 0â¤<italic>p</italic><sub><italic>k</italic>,<italic>i</italic></sub>â¤1 and <inline-formula id="IEq25"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\Sigma _{i=1}^{N} p_{k,i}=1$\end{document}</tex-math><mml:math id="M60"><mml:msubsup><mml:mrow><mml:mi>Î£</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq25.gif"/></alternatives></inline-formula>, we consider the following parameter transformation:
<disp-formula id="Equc"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document} $$\begin{array}{*{20}l} p_{k,i_{k}}=&amp;\frac{\exp(\omega_{k,i_{k}})}{\sum \limits^{m_{j}-1}_{l=1}\exp(\omega_{l,i_{l}})+1},~k=1,...,m_{j}-1 \textrm{ and } p_{m_{j},i_{m_{j}}}\\=&amp;\frac{1}{\sum \limits^{m_{j}-1}_{l=1}\exp(\omega_{l,i_{l}})+1} \end{array} $$ \end{document}</tex-math><mml:math id="M62"><mml:mtable class="align" columnalign="left"><mml:mtr><mml:mtd class="align-1"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo></mml:mtd><mml:mtd class="align-2"><mml:mfrac><mml:mrow><mml:mo>exp</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>Ï</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo mathsize="big">â</mml:mo></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:mo>exp</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>Ï</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="1em"/><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>...</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mn>1</mml:mn><mml:mtext>and</mml:mtext><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mspace width="2em"/></mml:mtd><mml:mtd><mml:mspace width="2em"/></mml:mtd></mml:mtr><mml:mtr><mml:mtd class="align-1"><mml:mo>=</mml:mo></mml:mtd><mml:mtd class="align-2"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo mathsize="big">â</mml:mo></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:mo>exp</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>Ï</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mspace width="2em"/></mml:mtd><mml:mtd><mml:mspace width="2em"/></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="12859_2019_3218_Article_Equc.gif" position="anchor"/></alternatives></disp-formula></p>
      <p>where <inline-formula id="IEq26"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\omega _{k,i_{k}}$\end{document}</tex-math><mml:math id="M64"><mml:msub><mml:mrow><mml:mi>Ï</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2019_3218_Article_IEq26.gif"/></alternatives></inline-formula>âs are unconstrained parameters whose estimates are obtained by the Nelder and Mead method.</p>
    </sec>
    <sec id="Sec18">
      <title>Pathway definition</title>
      <p>We consider 9 key cancer pathways from the KEGG database [<xref ref-type="bibr" rid="CR22">22</xref>] in our real data analysis. To minimize overlaps between pathways, the pathway genes connected by âO or eâ (transcriptional regulation), â- - -â (indirect regulation) or " ||â (cell membrane) are separated. Only the âcoreâ pathway genes are selected. For the apoptosis pathway, PI3K and RAS were excluded but TP53 was included. This is because PI3K and RAS pathway regulate the transcription of apoptosis genes, while TP53 not only regulates transcription, but also has transcription-independent function in apoptosis. For the PI3K-Akt signaling pathway, all genes downstream of AKT were excluded because they belong to other pathways that are defined as independent pathways in the KEGG database. The defined gene sets for each pathway are listed in Table S1 in Additional fileÂ <xref rid="MOESM2" ref-type="media">2</xref> and displayed in Figures S1-S9 in Additional fileÂ <xref rid="MOESM1" ref-type="media">1</xref>.</p>
    </sec>
  </sec>
  <sec id="Sec19">
    <title>Availability and requirements</title>
    <p><bold>Project name:</bold> PATOPA<bold>Project home page:</bold><ext-link ext-link-type="uri" xlink:href="https://github.com/MarkeyBBSRF/PATOPA">https://github.com/MarkeyBBSRF/PATOPA</ext-link>.<bold>Operating system(s):</bold> Linux or Windows<bold>Programming language:</bold> R, C<bold>Other requirements:</bold> R 3.3.2, gcc 4.2.1<bold>License:</bold> GNU GPL<bold>Any restrictions to use by non-academics:</bold> None</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec20">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12859_2019_3218_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1</bold> Figures S1-S9 display the âcoreâ pathway genes in each of the 9 key cancer pathways used in the paper. Figure S10 shows the distribution of the number of functional mutations in pairs of pathways. Figure S11 compares the temporal orders of pathway alterations inferred by PATOPA with the literature. Figure S12 shows the distribution of PolyPhen-2 scores in each pathway. Figure S13 shows the inferred temporal order of pathway mutations from TCGA rectal and colon data based on H-CBN.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
      <p>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="12859_2019_3218_MOESM2_ESM.csv">
            <caption>
              <p><bold>Additional file 2</bold> Table S1 provides a list of âcoreâ pathway genes in each of the 9 key cancer pathways considered in the paper.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>TCGA</term>
        <def>
          <p>The Cancer Genome Atlas</p>
        </def>
      </def-item>
      <def-item>
        <term>KEGG</term>
        <def>
          <p>Kyoto Encyclopedia of Genes and Genomes</p>
        </def>
      </def-item>
      <def-item>
        <term>Wnt</term>
        <def>
          <p>Wingless-related integration site</p>
        </def>
      </def-item>
      <def-item>
        <term>MAPK</term>
        <def>
          <p>Mitogen-activated protein kinase</p>
        </def>
      </def-item>
      <def-item>
        <term>PI3K</term>
        <def>
          <p>Phosphoinositide 3-kinase</p>
        </def>
      </def-item>
      <def-item>
        <term>TGF-beta</term>
        <def>
          <p>Transforming growth factor beta</p>
        </def>
      </def-item>
      <def-item>
        <term>VEGF</term>
        <def>
          <p>Vascular endothelial growth factor</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisherâs Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12859-019-3218-2.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authorsâ contributions</title>
    <p>CL and CW designed the study. MW, LC, AJS and CW derived the method. MW and JL implemented the method and performed simulation studies and real data analyses. TY, CL, JLV and SMA interpreted the data analysis results, MW, TY, LC, AJS, JLV, SMA, CL and CW wrote the manuscript. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by National Institutes of Health (NIH) [R21CA205778, UL1TR001998, P20GM103436-15 and the Cloud Credits Model Pilot, a component of the NIH Big Data to Knowledge (BD2K) program], the Kentucky Lung Cancer Research Program [PO2 415 1400004000, PO2 415 1600001032], and the Biostatistics and Bioinformatics Shared Resource Facility of the University of Kentucky Markey Cancer Center [P30 CA177558]. None of the funding bodies played any roles in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>PATOPA is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/MarkeyBBSRF/PATOPA">https://github.com/MarkeyBBSRF/PATOPA</ext-link>.</p>
  </notes>
  <notes>
    <title>Ethics approval and consent to participate</title>
    <p>Not applicable.</p>
  </notes>
  <notes>
    <title>Consent for publication</title>
    <p>Not applicable.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p>The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1</label>
      <mixed-citation publication-type="other">Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Prim. 2015. 12;ePub ahead of print. 10.1038/nrdp.2015.65.</mixed-citation>
    </ref>
    <ref id="CR2">
      <label>2</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Desper</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kallioniemi</surname>
            <given-names>OP</given-names>
          </name>
          <name>
            <surname>Moch</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Papadimitriou</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>SchÃ¤ffer</surname>
            <given-names>AA</given-names>
          </name>
        </person-group>
        <article-title>Inferring tree models for oncogenesis from comparative genome hybridization data</article-title>
        <source>J Comput Biol</source>
        <year>1999</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>37</fpage>
        <lpage>51</lpage>
        <pub-id pub-id-type="doi">10.1089/cmb.1999.6.37</pub-id>
        <?supplied-pmid 10223663?>
        <pub-id pub-id-type="pmid">10223663</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Szabo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Boucher</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Estimating an oncogenetic tree when false negatives and positives are present</article-title>
        <source>Math Biosci</source>
        <year>2002</year>
        <volume>176</volume>
        <issue>2</issue>
        <fpage>219</fpage>
        <lpage>36</lpage>
        <pub-id pub-id-type="doi">10.1016/S0025-5564(02)00086-X</pub-id>
        <?supplied-pmid 11916510?>
        <pub-id pub-id-type="pmid">11916510</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>RahnenfÃ¼hrer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>DÃ¤umer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hoffmann</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kaiser</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Selbig</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Learning multiple evolutionary pathways from cross-sectional data</article-title>
        <source>J Comput Biol</source>
        <year>2005</year>
        <volume>12</volume>
        <issue>6</issue>
        <fpage>584</fpage>
        <lpage>98</lpage>
        <pub-id pub-id-type="doi">10.1089/cmb.2005.12.584</pub-id>
        <?supplied-pmid 16108705?>
        <pub-id pub-id-type="pmid">16108705</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Antal</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Dingli</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Traulsen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kinzler</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Velculescu</surname>
            <given-names>VE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic progression and the waiting time to cancer</article-title>
        <source>PLoS Comput Biol</source>
        <year>2007</year>
        <volume>3</volume>
        <issue>11</issue>
        <fpage>e225</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.0030225</pub-id>
        <?supplied-pmid 17997597?>
        <pub-id pub-id-type="pmid">17997597</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Eriksson</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sturmfels</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Conjunctive bayesian networks</article-title>
        <source>Bernoulli</source>
        <year>2007</year>
        <volume>13</volume>
        <issue>4</issue>
        <fpage>893</fpage>
        <lpage>909</lpage>
        <pub-id pub-id-type="doi">10.3150/07-BEJ6133</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sullivant</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Markov models for accumulating mutations</article-title>
        <source>Biometrika</source>
        <year>2009</year>
        <volume>96</volume>
        <issue>3</issue>
        <fpage>645</fpage>
        <lpage>61</lpage>
        <pub-id pub-id-type="doi">10.1093/biomet/asp023</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Farahani</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Lagergren</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Learning oncogenetic networks by reducing to mixed integer linear programming</article-title>
        <source>PloS One</source>
        <year>2013</year>
        <volume>8</volume>
        <issue>6</issue>
        <fpage>e65773</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0065773</pub-id>
        <pub-id pub-id-type="pmid">23799047</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sakoparnig</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Efficient sampling for Bayesian inference of conjunctive Bayesian networks</article-title>
        <source>Bioinformatics</source>
        <year>2012</year>
        <volume>28</volume>
        <issue>18</issue>
        <fpage>2318</fpage>
        <lpage>24</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts433</pub-id>
        <?supplied-pmid 22782551?>
        <pub-id pub-id-type="pmid">22782551</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Attolini</surname>
            <given-names>CSO</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>YK</given-names>
          </name>
          <name>
            <surname>Beroukhim</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Getz</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Abdel-Wahab</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>RL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A mathematical framework to determine the temporal sequence of somatic genetic events in cancer</article-title>
        <source>Proc Natl Acad Sci</source>
        <year>2010</year>
        <volume>107</volume>
        <issue>41</issue>
        <fpage>17604</fpage>
        <lpage>9</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1009117107</pub-id>
        <?supplied-pmid 20864632?>
        <pub-id pub-id-type="pmid">20864632</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cristea</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kuipers</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>pathTiMEx: joint inference of mutually exclusive cancer pathways and their progression dynamics</article-title>
        <source>J Comput Biol</source>
        <year>2017</year>
        <volume>24</volume>
        <issue>6</issue>
        <fpage>603</fpage>
        <lpage>15</lpage>
        <pub-id pub-id-type="doi">10.1089/cmb.2016.0171</pub-id>
        <?supplied-pmid 27936934?>
        <pub-id pub-id-type="pmid">27936934</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Youn</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Simon</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Estimating the order of mutations during tumorigenesis from tumor genome sequencing data</article-title>
        <source>Bioinformatics</source>
        <year>2012</year>
        <volume>28</volume>
        <issue>12</issue>
        <fpage>1555</fpage>
        <lpage>61</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts168</pub-id>
        <?supplied-pmid 22492649?>
        <pub-id pub-id-type="pmid">22492649</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Leiserson</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>HT</given-names>
          </name>
          <name>
            <surname>Vandin</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Raphael</surname>
            <given-names>BJ</given-names>
          </name>
        </person-group>
        <article-title>CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer</article-title>
        <source>Genome Biol</source>
        <year>2015</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>160</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-015-0700-7</pub-id>
        <?supplied-pmid 26253137?>
        <pub-id pub-id-type="pmid">26253137</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Constantinescu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Szczurek</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mohammadi</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>RahnenfÃ¼hrer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>TiMEx: a waiting time model for mutually exclusive cancer alterations</article-title>
        <source>Bioinformatics</source>
        <year>2015</year>
        <volume>32</volume>
        <issue>7</issue>
        <fpage>968</fpage>
        <lpage>75</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btv400</pub-id>
        <?supplied-pmid 26163509?>
        <pub-id pub-id-type="pmid">26163509</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gerstung</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eriksson</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vogelstein</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>The temporal order of genetic and pathway alterations in tumorigenesis</article-title>
        <source>PloS One</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>11</issue>
        <fpage>e27136</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0027136</pub-id>
        <?supplied-pmid 22069497?>
        <pub-id pub-id-type="pmid">22069497</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>YK</given-names>
          </name>
          <name>
            <surname>Beroukhim</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Mellinghoff</surname>
            <given-names>IK</given-names>
          </name>
          <name>
            <surname>Holland</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Michor</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis</article-title>
        <source>PLoS Comput Biol</source>
        <year>2012</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>e1002337</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1002337</pub-id>
        <?supplied-pmid 22241976?>
        <pub-id pub-id-type="pmid">22241976</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raphael</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Vandin</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data</article-title>
        <source>J Comput Biol</source>
        <year>2015</year>
        <volume>22</volume>
        <issue>6</issue>
        <fpage>510</fpage>
        <lpage>27</lpage>
        <pub-id pub-id-type="doi">10.1089/cmb.2014.0161</pub-id>
        <?supplied-pmid 25785493?>
        <pub-id pub-id-type="pmid">25785493</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ng</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Henikoff</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>
        <source>Nucleic Acids Res</source>
        <year>2003</year>
        <volume>31</volume>
        <issue>13</issue>
        <fpage>3812</fpage>
        <lpage>4</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>
        <?supplied-pmid 12824425?>
        <pub-id pub-id-type="pmid">12824425</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Adzhubei</surname>
            <given-names>IA</given-names>
          </name>
          <name>
            <surname>Schmidt</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Peshkin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ramensky</surname>
            <given-names>VE</given-names>
          </name>
          <name>
            <surname>Gerasimova</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A method and server for predicting damaging missense mutations</article-title>
        <source>Nat Methods</source>
        <year>2010</year>
        <volume>7</volume>
        <issue>4</issue>
        <fpage>248</fpage>
        <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
        <?supplied-pmid 20354512?>
        <pub-id pub-id-type="pmid">20354512</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Reva</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Antipin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Predicting the functional impact of protein mutations: application to cancer genomics</article-title>
        <source>Nucleic Acids Res</source>
        <year>2011</year>
        <volume>39</volume>
        <issue>17</issue>
        <fpage>e118</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkr407</pub-id>
        <?supplied-pmid 21727090?>
        <pub-id pub-id-type="pmid">21727090</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sims</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>
        <source>PloS One</source>
        <year>2012</year>
        <volume>7</volume>
        <issue>10</issue>
        <fpage>e46688</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0046688</pub-id>
        <?supplied-pmid 23056405?>
        <pub-id pub-id-type="pmid">23056405</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanehisa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title>
        <source>Nucleic Acids Res</source>
        <year>2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>27</fpage>
        <lpage>30</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id>
        <?supplied-pmid 10592173?>
        <pub-id pub-id-type="pmid">10592173</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23</label>
      <mixed-citation publication-type="other">The Cancer Genome Atlas Network, et al.Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012; 487(7407):330â7. 10.1038/nature11252.</mixed-citation>
    </ref>
    <ref id="CR24">
      <label>24</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiao</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Vembu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Deshwar</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Stein</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Inferring clonal evolution of tumors from single nucleotide somatic mutations</article-title>
        <source>BMC Bioinformatics</source>
        <year>2014</year>
        <volume>15</volume>
        <issue>1</issue>
        <fpage>35</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-15-35</pub-id>
        <?supplied-pmid 24484323?>
        <pub-id pub-id-type="pmid">24484323</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>RomÃ¡n</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Baraibar</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>LÃ³pez</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Nadal</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rolfo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vicent</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target</article-title>
        <source>Mol Cancer</source>
        <year>2018</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>33</fpage>
        <pub-id pub-id-type="doi">10.1186/s12943-018-0789-x</pub-id>
        <?supplied-pmid 29455666?>
        <pub-id pub-id-type="pmid">29455666</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Murali</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sivakumaran</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Moseley</surname>
            <given-names>HN</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Characterization of squamous cell lung cancers from Appalachian Kentucky</article-title>
        <source>Cancer Epidemiol Biomarkers Prev</source>
        <year>2019</year>
        <volume>28</volume>
        <issue>2</issue>
        <fpage>348</fpage>
        <lpage>56</lpage>
        <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-17-0984</pub-id>
        <?supplied-pmid 30377206?>
        <pub-id pub-id-type="pmid">30377206</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pacheco-Pinedo</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Morrisey</surname>
            <given-names>EE</given-names>
          </name>
        </person-group>
        <article-title>Wnt and Kras signaling-dark siblings in lung cancer</article-title>
        <source>Oncotarget</source>
        <year>2011</year>
        <volume>2</volume>
        <issue>7</issue>
        <fpage>569</fpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.305</pub-id>
        <?supplied-pmid 21753228?>
        <pub-id pub-id-type="pmid">21753228</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shtivelman</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hensing</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Simon</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Dennis</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Otterson</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Bueno</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Molecular pathways and therapeutic targets in lung cancer</article-title>
        <source>Oncotarget</source>
        <year>2014</year>
        <volume>5</volume>
        <issue>6</issue>
        <fpage>1392</fpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.1891</pub-id>
        <?supplied-pmid 24722523?>
        <pub-id pub-id-type="pmid">24722523</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Leiserson</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Reyna</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Raphael</surname>
            <given-names>BJ</given-names>
          </name>
        </person-group>
        <article-title>A weighted exact test for mutually exclusive mutations in cancer</article-title>
        <source>Bioinformatics</source>
        <year>2016</year>
        <volume>32</volume>
        <issue>17</issue>
        <fpage>i736</fpage>
        <lpage>45</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btw462</pub-id>
        <?supplied-pmid 27587696?>
        <pub-id pub-id-type="pmid">27587696</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dai</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Breast cancer intrinsic subtype classification, clinical use and future trends</article-title>
        <source>Am J Cancer Res</source>
        <year>2015</year>
        <volume>5</volume>
        <issue>10</issue>
        <fpage>2929</fpage>
        <?supplied-pmid 26693050?>
        <pub-id pub-id-type="pmid">26693050</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Perez-Moreno</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Brambilla</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Soria</surname>
            <given-names>JC</given-names>
          </name>
        </person-group>
        <article-title>Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities</article-title>
        <source>Clin Cancer Res</source>
        <year>2012</year>
        <volume>18</volume>
        <issue>9</issue>
        <fpage>2443</fpage>
        <lpage>51</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-2370</pub-id>
        <?supplied-pmid 22407829?>
        <pub-id pub-id-type="pmid">22407829</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brennan</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Verhaak</surname>
            <given-names>RG</given-names>
          </name>
          <name>
            <surname>McKenna</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Campos</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Noushmehr</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Salama</surname>
            <given-names>SR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The somatic genomic landscape of glioblastoma</article-title>
        <source>Cell</source>
        <year>2013</year>
        <volume>155</volume>
        <issue>2</issue>
        <fpage>462</fpage>
        <lpage>77</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.09.034</pub-id>
        <?supplied-pmid 24120142?>
        <pub-id pub-id-type="pmid">24120142</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33</label>
      <mixed-citation publication-type="other">Verhaak RG, Tamayo P, Yang JY, Hubbard D, Zhang H, Creighton CJ, et al.Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J Clin Inv. 2012; 123(1).</mixed-citation>
    </ref>
    <ref id="CR34">
      <label>34</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McGranahan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Swanton</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Clonal heterogeneity and tumor evolution: past, present, and the future</article-title>
        <source>Cell</source>
        <year>2017</year>
        <volume>168</volume>
        <issue>4</issue>
        <fpage>613</fpage>
        <lpage>28</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2017.01.018</pub-id>
        <?supplied-pmid 28187284?>
        <pub-id pub-id-type="pmid">28187284</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stanta</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bonin</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Overview on clinical relevance of intra-tumor heterogeneity</article-title>
        <source>Front Med</source>
        <year>2018</year>
        <volume>5</volume>
        <fpage>85</fpage>
        <pub-id pub-id-type="doi">10.3389/fmed.2018.00085</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schwartz</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>SchÃ¤ffer</surname>
            <given-names>AA</given-names>
          </name>
        </person-group>
        <article-title>The evolution of tumour phylogenetics: principles and practice</article-title>
        <source>Nat Rev Genet</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>4</issue>
        <fpage>213</fpage>
        <pub-id pub-id-type="doi">10.1038/nrg.2016.170</pub-id>
        <?supplied-pmid 28190876?>
        <pub-id pub-id-type="pmid">28190876</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Deshwar</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Vembu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yung</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Jang</surname>
            <given-names>GH</given-names>
          </name>
          <name>
            <surname>Stein</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors</article-title>
        <source>Genome Biol</source>
        <year>2015</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>35</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-015-0602-8</pub-id>
        <?supplied-pmid 25786235?>
        <pub-id pub-id-type="pmid">25786235</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schwarz</surname>
            <given-names>RF</given-names>
          </name>
          <name>
            <surname>Trinh</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sipos</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Brenton</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Goldman</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Markowetz</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Phylogenetic quantification of intra-tumour heterogeneity</article-title>
        <source>PLoS Comput Biol</source>
        <year>2014</year>
        <volume>10</volume>
        <issue>4</issue>
        <fpage>e1003535</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003535</pub-id>
        <?supplied-pmid 24743184?>
        <pub-id pub-id-type="pmid">24743184</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zong</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chapman</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>XS</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide detection of single-nucleotide and copy-number variations of a single human cell</article-title>
        <source>Science</source>
        <year>2012</year>
        <volume>338</volume>
        <issue>6114</issue>
        <fpage>1622</fpage>
        <lpage>6</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1229164</pub-id>
        <?supplied-pmid 23258894?>
        <pub-id pub-id-type="pmid">23258894</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Single cell sequencing: a distinct new field</article-title>
        <source>Clin Transl Med</source>
        <year>2017</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>10</fpage>
        <pub-id pub-id-type="doi">10.1186/s40169-017-0139-4</pub-id>
        <?supplied-pmid 28220395?>
        <pub-id pub-id-type="pmid">28220395</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Maslov</surname>
            <given-names>AY</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vijg</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Single-cell whole-genome sequencing reveals the functional landscape of somatic mutations in B lymphocytes across the human lifespan</article-title>
        <source>Proc Natl Acad Sci</source>
        <year>2019</year>
        <volume>116</volume>
        <issue>18</issue>
        <fpage>9014</fpage>
        <lpage>9</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1902510116</pub-id>
        <?supplied-pmid 30992375?>
        <pub-id pub-id-type="pmid">30992375</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ross</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Markowetz</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>OncoNEM: inferring tumor evolution from single-cell sequencing data</article-title>
        <source>Genome Biol</source>
        <year>2016</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>69</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-016-0929-9</pub-id>
        <?supplied-pmid 27083415?>
        <pub-id pub-id-type="pmid">27083415</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jahn</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kuipers</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Tree inference for single-cell data</article-title>
        <source>Genome Biol</source>
        <year>2016</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>86</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-016-0936-x</pub-id>
        <?supplied-pmid 27149953?>
        <pub-id pub-id-type="pmid">27149953</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44</label>
      <mixed-citation publication-type="other">Graphviz - Graph visualization software. <ext-link ext-link-type="uri" xlink:href="https://www.graphviz.org">https://www.graphviz.org</ext-link>.</mixed-citation>
    </ref>
    <ref id="CR45">
      <label>45</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bansal</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Blum</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chawla</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Correlation clustering</article-title>
        <source>Mach Learn</source>
        <year>2004</year>
        <volume>56</volume>
        <issue>1-3</issue>
        <fpage>89</fpage>
        <lpage>113</lpage>
        <pub-id pub-id-type="doi">10.1023/B:MACH.0000033116.57574.95</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
